Status:

COMPLETED

Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole

Lead Sponsor:

Radboud University Medical Center

Conditions:

Hyperemia

Hypoxia

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether dipyridamole enhances postocclusive reactive hyperaemia by increasing extracellular adenosine concentrations during ischemia and reperfusion. Furtherm...

Eligibility Criteria

Inclusion

  • healthy volunteers between 18 and 50 years

Exclusion

  • none specified

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2006

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00268554

Start Date

December 1 2005

End Date

July 1 2006

Last Update

March 28 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Radboud university Nijmegen Medical Centre

Nijmegen, Gelderland, Netherlands, 6533 ZA